Localisation and toxicity study of a vindesine-anti-CEA conjugate in patients with advanced cancer.

Safety of administration of a vindesine (VDS)-anti-CEA conjugate and its ability to localise after radiolabelling were investigated in patients with advanced metastatic carcinoma (4 colorectal and 4 ovarian). For imaging, patients received between 230 and 520 micrograms of 131I labelled antibody. In...

Descripción completa

Detalles Bibliográficos
Autores principales: Ford, C. H., Newman, C. E., Johnson, J. R., Woodhouse, C. S., Reeder, T. A., Rowland, G. F., Simmonds, R. G.
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 1983
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2011264/
https://www.ncbi.nlm.nih.gov/pubmed/6821632

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2011264/
https://www.ncbi.nlm.nih.gov/pubmed/6821632

Ejemplares similares